NGS-basert diagnostikk og diagnostiske verktøy
Digital Tools to Drive NGS Clinical Application for the Future
December 12, 2020, 57min
The amount of clinical data available for each patient has grown exponentially in the past decade. Clinicians are managing massive genomic information, histological analysis tools, and an explosion of clinical trials and publications. They must depend on connecting with other clinicians through multi-disciplinary tumour board meetings and digital tools to support decision making. In this webinar Assoc. Prof. Jason CH Hsieh, Tucheng Hospital and Chang Gung Memorial Hospital, Linkou, Taiwan and Assoc. Prof. Svetlana Cherepanoff, St Vincent’s Hospital, Australia, explore the potential of using digital clinical analysis and communication tools to help make optimal patient decisions
Lung Cancer Diagnostics: Evolving Practice and Future Directions
May 21 2020, 60 minutter
Professor Keith Kerr, University of Aberdeen, UK. Personalized medicine for non-small-cell lung cancer (NSCLC) continues to evolve rapidly, building on a solid diagnostic foundation based on H&E and immunohistochemistry (IHC), incorporating predictive biomarker testing for oncogene-directed therapies and immunotherapies. Understanding the role of biomarker testing, different technologies and latest developments is vitally important for practicing pathologists.
During this Bright TALK webinar, Professor Keith Kerr will review the current diagnostic pathways in lung cancer, outline the role of IHC and molecular testing, differentiate oncogene biomarkers from immunotherapy biomarkers, and share his perspectives on future directions in lung cancer testing, including multiplexed assays.
Clinical decision support in the NGS Oncology workflow
May 7 2020, 55 minutter
Dr. Stephanie Yaung, Medical Affairs Roche. The increasing adoption of next generation sequencing (NGS) in molecular profiling of cancer presents a need for streamlined result interpretation in clinical labs. With growing complexity of NGS results, evolving guidelines, and fragmented data sources, clinical decision support (CDS) systems can facilitate reporting of clinically relevant variants. In this talk, our speaker will discuss how software capable of automatically interpreting and presenting clinically relevant information reduces the need for time-consuming and error-prone manual curation.